ADHD Assessment
ADHD Assessment

ADHD Assessment

Accurate ADHD assessments for children, adolescents, and adults. Identify symptoms early and improve daily functioning. Book your assessment today.

Book telehealth call OR Book prescription only

Book telehealth call
OR Book prescription only

What is ADHD Assessmentand When Should You Consider It?

An ADHD Assessment evaluates attention, hyperactivity, and impulsivity to determine whether ADHD is present. The assessment provides a clear diagnosis and guides tailored support, helping individuals manage symptoms effectively.

ADHD Assessment

Our ADHD Assessment Services

ADHD Adolescent Assessment

Comprehensive evaluation for teens, including family and school input.
£ 370
  • 45–50 min
  • Remote Sessions
  • Interviews with adolescent and family
  • Behavioral questionnaires and school reports
  • Personalized treatment recommendations

ADHD Adult Assessment

Focused assessment for adults struggling with attention, organization, and daily functioning.
£ 370
  • 45–50 min
  • Remote Sessions
  • Evaluation of work, social, and personal impact
  • Symptom-focused questionnaires and interviews
  • Tailored strategies for symptom management

ADHD Computerized Assessment

Objective, computer-based testing for accurate ADHD diagnosis in children and adults.
£ 470
  • 45–60 min
  • Remote Sessions
  • Attention and impulse control measurement
  • Detailed analysis report
  • Data-driven guidance for next steps

Note

How the ADHD Assessment Process Works

Complete pre-assessment questionnaires and risk evaluation

Attend in-person or remote consultation

Clinical evaluation and symptom analysis

Receive a clear diagnosis and individualized recommendations

Discuss treatment options, follow-ups, or additional assessments

Private Consultant Psychiatrist

Why Chooseprof. Ahmed EL-Missiry?

ADHD Assessment Frequently Asked Questions

Yes. In the UK, psychiatrists are the primary specialists for diagnosing ADHD and initiating medication. They assess your symptoms against clinical criteria and monitor the biological effects of treatment. While GPs provide ongoing care, the initial specialist oversight ensures the most accurate management plan.

This is a self-regulation strategy used to manage impulsivity. It involves waiting 24 hours before acting on an impulse, such as making a non-essential purchase or responding to a sensitive email. This “cooling-off” period allows the brain to process the urge logically rather than emotionally.

Establish a “low-dopamine” wind-down routine. Dim the lights and avoid screens an hour before sleep to encourage melatonin production. Many find sensory tools, like weighted blankets or white noise, helpful. Consistent sleep hygiene is vital for regulating the often-disrupted circadian rhythms associated with ADHD.

Focus on “externalising” your executive functions. Use digital timers, visual planners, and body-doubling (working alongside someone else). Instead of radical changes, implement small, dopamine-friendly habits. Prioritising sleep, nutrition, and professional coaching can help build a sustainable environment that works with your brain, not against it.

Specialists often identify early adolescence (ages 12–15) or the transition to early adulthood as the most challenging. These periods involve a significant increase in academic demands and social complexity, often outpacing the development of executive functioning skills such as planning, emotional regulation, and self-organisation.

Treatment in Japan typically involves a combination of pharmaceutical intervention and psychosocial support. Common medications include methylphenidate (Concerta) and atomoxetine (Strattera). Japan is known for rigorous diagnostic standards and a strong emphasis on environmental adjustments within the school system to support neurodivergent students.

While global prevalence is approximately 5%, reported rates are highest in countries like the United States and Israel. This is largely attributed to advanced screening protocols, greater public awareness, and differences in diagnostic criteria compared to other nations, where ADHD may still be under-diagnosed.

Recent developments include “digital therapeutics”—specifically designed video games that improve attention—and new non-stimulant medications like Viloxazine. Research is also expanding into neuromodulation, such as Trigeminal Nerve Stimulation (TNS), which offers a non-invasive, non-pharmacological option for managing symptoms during sleep.

Proposed by Dr Russell Barkley, this rule suggests that individuals with ADHD often have an “executive age” roughly 30% behind their chronological age. For instance, a 10-year-old may have the self-regulation skills of a 7-year-old. This perspective helps in setting realistic expectations for development and independence.